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Colibactin, a genotoxin, encoded by the pks pathogenicity island of Escherichia coli
belonging to the B2 phylogroup has been reported as a determinant of bacterial
pathogenicity. The present study was carried out to detect the pks pathogenicity
island in extraintestinal pathogenic E. coli (ExPEC) isolated from a tertiary hospital in
Pune, India. Of 462 isolates analyzed, the pks genomic island was detected in 35
(7.6%) isolates, which predominantly belonged to pathogenic phylogroup B2 (97%),
and harbored virulence genes such as fimH, sfaD/E, and usp. Biofilm formation assay
revealed 21 of the 35 pks-carrying isolates to be strong (SBF > 1.0), 10 isolates to be
moderate (SBF = 0.5–1.0), and 4 as weak (SBF < 0.5) biofilm formers. All of the pks-
carrying isolates proved resistant against bactericidal activity of human serum. Assays
carried out to detect antimicrobial susceptibility revealed 11% of these isolates to be
multidrug resistant, 37% producing ESBL and 25% were positive for blaCTX−M−15. The
observed prevalence of multidrug resistance and colibactin producing characteristics
among pathogenic E. coli belonging to phylogenetic group B2 advocate urgent need for
broader surveillance in order to understand and prevent transmission of these ExPEC in
community and hospital settings.
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INTRODUCTION
Extraintestinal pathogenic Escherichia coli (ExPEC), apart from being a seasoned nosocomial
pathogen is also an important cause of community-acquired (Johnson and Russo, 2002) and other
infections such as urinary tract infection, sepsis, neonatal meningitis, and colibacillosis in humans
and animals (Kaper et al., 2004; Smith et al., 2007). Genome analysis revealed that pathogenic
E. coli have genome sizes in excess of about 1.0 Mb than the commensal strains mainly due to
the presence of genes encoding multiple virulence factors, such as adhesins, toxins, invasins and
siderophores that are absent or unlikely to be present in commensal strains (Croxen and Finlay,
2010). The virulence factors are mostly associated with phages and pathogenicity islands and
undergo horizontal gene transfer which disseminates traits, thereby offering fitness advantages to
recipient organisms (Ahmed et al., 2008).
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Secreted toxins are the virulence factors that play an important
role in long term colonization and pathogenesis of ExPEC.
Some of these known secreted toxins comprise of important
genotoxins, such as cytolethal distending toxins (CDT’s), cycle
inhibiting factors (cif ’s) and cytotoxic necrotizing factors (CNF’s)
which can directly regulate the cell cycle of the host (Nougayrède
et al., 2005). Colibactin is another important genotoxin produced
by a 54-kb pathogenicity island known as pks island harbored
by the members of Enterobacteriaceae (Nougayrède et al., 2006).
This genomic island consists of a clbA-S gene cluster that
encodes non-ribosomal peptides and polyketide synthases along
with accessory and tailoring enzymes (Nougayrède et al., 2006).
Colibactin acts as a cyclomodulin and blocks the eukaryotic cell
cycle causing progressive enlargement of the nucleus as well as
the cell body eventually leading to cell death (Cuevas-Ramos
et al., 2010). The cytopathic effect of these genotoxins is mediated
by live bacteria and requires a direct contact with the host cell
(Nougayrède et al., 2006).
The pks island was first identified in sequenced genomes of
ExPEC prototype strains and was detected predominantly in
strains of phylogenetic group B2 (Johnson et al., 2008). The
island was shown to display several signatures reminiscent of its
horizontal acquisition (Putze et al., 2009; Messerer et al., 2017).
The origin and prevalence of the colibactin island among enteric
pathogens is largely unexplored. However, it was also found
to be present in other members of Enterobacteriaceae such as
Citrobacter koseri, Klebsiella pneumoniae, and Enterobacter
aerogenes (Putze et al., 2009). Epidemiological studies
demonstrated the prevalence of pks in ExPEC and their
association with severe infections in different host populations
of varied geographical locations (Johnson et al., 2008; Buc et al.,
2013; Shimpoh et al., 2017).
Epidemiological studies on ExPEC in India have so far been
focused on understanding antimicrobial resistance, evolution and
presence of pandemic clones (Avasthi et al., 2011; Jadhav et al.,
2011; Hussain et al., 2012, 2014; Shaik et al., 2017). However, a
better understanding of ExPEC associated virulence factors may
help in the development of therapeutic interventions, such as
diagnostics and/or vaccines against ExPEC infections, and this
would also facilitate risk assessment of ExPEC strains.
While colibactin is regarded as a virulence factor in ExPEC,
not much is known in the context of its molecular epidemiology
entailing Indian clinical isolates. Therefore, the present study was
performed in order to investigate the prevalence and carriage
of pks island, and to decipher the genotypic and functional




A total of 462 isolates of ExPEC were harnessed for this study.
These isolates were originally collected by SJ and her colleagues
from Dr D. Y. Patil University Hospital, Pune, India as a part
of their routine diagnostic screening during the years 2009–2015
and were also described in our previous study (Ranjan et al.,
2016). The bacterial collection of our study, essentially a sub-
set of the collection studied by Ranjan et al. (2016), comprised
370 isolates cultured from urine, 63 from pus and 29 from
other extra intestinal clinical samples. Standard microbiological
laboratory methods were employed for the identification and
preservation of these isolates (Jadhav et al., 2011). All isolates
were collected, preserved and handled as per standard biosafety
guidelines and according to the approvals of the Institutional
Biosafety Committee (IBSC) of the University of Hyderabad
(Ref. UH/IBSC/NA/12/7 dated 09/4/2012 and NA-N-32 dated
27/8/2015). The clinical information of the isolates is described
in the Supplementary Table S1.
Detection of pks-Genomic Island and
Phylogroup Determination
The clinical isolates were screened for the presence of pks island
by PCR using primers for the four representative genes of
the genomic island so as to generate two flanking (clbB and
clbQ) and two internal (clbA and clbN) amplicons in order to
document presence of a complete island (Johnson et al., 2008).
Heat killed bacterial lysates were used as DNA templates for PCR
amplification, as described previously (Ranjan et al., 2017). PCR
amplifications were carried out in 30 cycles at specific reaction
conditions as described earlier (Johnson et al., 2008; Ranjan
et al., 2017). The pks-positive isolates were assigned to one of the
eight phylogroups based on multiplex-PCR amplification of four
genes (chuA, yjaA, arpA, and TspE4.C2) as described elsewhere
(Clermont et al., 2013).
Antibiotic Susceptibility and Extended
Spectrum-β-Lactamase Production
Antibiotic susceptibility analysis was performed, as previously
described, by Kirby-Bauer disk diffusion method, on Mueller
Hinton agar plates (Qumar et al., 2017). Antimicrobial
disks (Himedia, India) specific for fosfomycin (200 µg),
chloramphenicol (30 µg), co-trimoxazole (20 µg), tetracycline
(30 µg), gentamicin (10 µg), nalidixic acid (30 µg), doxycycline
(30 µg), ciprofloxacin (5 µg), and colistin (10 µg) were
used to determine the antibiotic susceptibility profile of the
isolates. ESBL production was determined using disk synergy
between clavulanic acid and indicator cephalosporins, CTX
(cefotaxime) and CAZ (ceftazidime). Both the assays were
performed in accordance with Clinical Laboratory Standards
Institute (CLSI) guidelines (CLSI, 2013). Isolates exhibiting
resistance to three or more antimicrobials were designated as
multidrug resistant (MDR).
Virulence and Antimicrobial Resistance
Genotyping
PCR based screening of virulence genes encoding bacterial
adhesins (fimH, sfaD/E, afa), toxins (usp, cvaC, sat), iron
acquisition system (iucD) and protectants (ibeA) were performed
using primers and reaction conditions as previously described
(Jadhav et al., 2011; Ranjan et al., 2017). ESBL gene blaCTX−M−15,
(Monstein et al., 2007), genes conferring resistance to tetracycline
(tetA), sulfonamides (sul1) and aminoglycoside acetyl transferases
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(aac(6′)-Ib) were also screened for using primers and PCR
conditions as described in previous studies (Jadhav et al., 2011;
Ranjan et al., 2016, 2017). The isolates were also screened by
PCR using generic primers for TEM and amplified products were
sequenced to identify the variants of the gene.
Determination of Siderophore
Production, Biofilm Formation and
Serum Resistance Assay
All the pks-positive isolates were screened for siderophore
production using Chrome Azurol S Blue agar plates. A single
colony of the bacterial isolate(s) was streaked on these plates
and incubated overnight at 37◦C. Colonies showing characteristic
orange halos were identified as positive for siderophore
production (Schwyn and Neilands, 1987).
All the 35 pks-positive isolates were analyzed for their biofilm
forming capabilities as described previously (Nandanwar et al.,
2014). Briefly, OD at 600 nm was taken for overnight grown
bacterial cultures and all the isolates were diluted to an OD of
0.05 in fresh M63 minimal medium. An aliquot of 200 µL of
the diluted culture was pipetted into flat-bottom 96 well sterile
microtiter plates in triplicates. The plates were covered by a
breathable sealing after obtaining OD at 600 nm [OD600(0 h)].
The plates were incubated for 48 h at stationary condition at
28◦C. Following this, OD was obtained at 600 nm [OD600(48 h)].
Media was aspirated and wells washed thrice with 300 µL of
deionized water. After air drying, bacteria were fixed using
250 µL of 99% methanol for 15 min and stained using 0.1%
crystal violet solution for 30 min. Following staining, wells
were washed thrice with deionized water and air dried. To
solubilize the stained bacteria, 300 µL of Ethanol: Acetone (80:20)
solution was added and incubated for 30 min at 100 rpm. OD
at 570 nm was read in microtiter plate reader and specific
biofilm formation was obtained using the following formula: SBF
(specific biofilm formation) = (AB−CW)/G where AB = OD at
570 nm of attached and stained bacteria, CW = OD of control
at 570 nm and G = OD600(48 h) − OD600(0 h), representing
bacterial growth. The experiment was repeated twice in technical
triplicates.
Serum resistance was also determined for all the 35 pks-
positive E. coli isolates in vitro using 50% human serum as
described earlier (Hussain et al., 2014). Briefly, 5 µL of overnight
culture was added to 495 µl of LB broth and incubated in a
shaking incubator at 37◦C for 1 h at 200 rpm. The bacterial
cultures were pelleted and resuspended in 1mL of 1X PBS;
30 µL of this inoculum was added to 270 µL of 50% human
serum in triplicates in a 96 well microtiter plate. In each case,
an initial sample was collected and plated after dilution on LB
agar plates for enumerating the colony forming units (CFU)
at 0 h. The inoculated plate was incubated for 3 h at 37◦C
at 100 rpm. After 3 h, samples from each well were serially
diluted and plated on LB agar plates for 3 h count. Isolates
which had equal or higher CFU counts at 3 h compared
to 0 h were considered resistant to human serum. Growth
was obtained by subtracting CFU counts of 0 h from that
of 3 h. The experiment was repeated two times in technical
triplicate(s).
Statistical Analysis
All statistical calculations were performed using GraphPad
Prism (version 5.01). Non-parametric Mann–Whitney U test
was performed for serum resistance assay. p-values ≤ 0.05 were
considered to be significant and were denoted in the graph.
RESULTS
Screening for pks Island and
Phylogenetic Grouping
A total of 462 E. coli isolates from our collection were screened
for the presence of pks island, of which 35 were found to be
positive for all the four targeted genes (clbA, clbB, clbN and clbQ)
amplified from flanking and internal regions. Of these, 30 were
originally cultured from urine, four from pus and one from blood.
The prevalence of pks-positive isolates was 7.6% of the total
E. coli collection studied. Using multiplex PCR, identification of
E. coli phylogenetic groups was performed and out of the 35
isolates, 34 belonged to phylogroup B2 while one was assigned
to phylogroup D (Table 1).
Antimicrobial Susceptibility and ESBL
Production
Antimicrobial susceptibility testing against nine different
antimicrobial agents belonging to seven different antibiotic
classes revealed that the isolates were only moderately resistant
to antibiotics. Maximum resistance was observed against
nalidixic acid (71.4%). The isolates were found to be less resistant
to tetracycline (22.86%), co-trimoxazole (14.29%), doxycycline
(11.43%), gentamicin (5.71%), and ciprofloxacin (5.71%) and
were completely sensitive to fosfomycin, chloramphenicol, and
colistin. Of the 35 E. coli isolates, 13 (37.14%) were found to be
ESBL producers and 4 (11.42%) were multidrug resistant. The
details of resistance profile(s) for each antibiotic tested are shown
in Table 1.
Virulence and Resistance Genotyping
PCR based virulence and resistance genotyping of pks-positive
isolates revealed their being relatively virulent as they possessed
higher number of virulence genes compared to the resistance
genes detected. Among bacterial adhesins tested, fimH and
sfaD/E were 100% prevalent while afa was not detected in any
of the isolates. Screening of toxin genes revealed presence of usp
gene among all the isolates (100%), whereas cvaC and sat showed
42.86% and 34.29% prevalence, respectively. The genes iucD (iron
acquisition system) and ibeA (protectant) were present in 51.43%
and 31.43% of the isolates, respectively (Table 1).
Antimicrobial resistance genotyping revealed that the ESBL
gene blaCTX−M−15 was present in 25.71% (n = 9) of the isolates
and all these isolates were phenotypically observed to be ESBL
producers by double disk synergy test. Further, 22.86% (n = 8)
of the isolates were positive for TEM, and sequencing of PCR
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TABLE 1 | Phylogroups, virulence and resistance genotypes, and antimicrobial resistance of pks-positive E. coli isolates.




Virulence factors: Genotypic determinant
Adhesins fimH 35 (100)
sfaD/E 35 (100)
afa 0 (0)
Toxins usp 35 (100)
sat 12 (34.29)
cvaC 15 (42.86)
Protectins ibeA 11 (31.43)
Iron acquisition iucD 18 (51.43)
Resistance factors: Antibiotic class
Tetracyclines tetA 2 (5.71)
Fluoroquinolones aac(6′)-Ib 7 (20)
Sulfonamides sul1 4 (11.43)
β-lactamases blaTEM−1 8 (22.86)
blaCTX−M−15 9 (25.71)
Antimicrobial class or phenotype Specific Drug No. (%) of resistant isolates
Aminoglycoside Gentamicin 2 (5.71)
Tetracyclines Tetracycline 8 (22.86)
Doxycycline 4 (11.43)
Sulfonamide/trimethoprim Co-trimoxazole 5 (14.29)
Phenicol Chloramphenicol 0 (0)
Phosphonic acid derivative Fosfomycin 0 (0)
Fluoroquinolone Ciprofloxacin 2 (5.71)
Nalidixic Acid 25 (71.43)
Antibacterial peptide Colistin 0 (0)
Multidrug Resistance 4 (11.42)
ESBL 13 (37.14)
products followed by BLAST analysis identified all the amplicons
to be entailing blaTEM−1. The gene aac(6′)-Ib, which is involved
in aminoglycoside resistance, was present in 20% of the pks-
positive isolates. Occurrence of genes that confer sulfonamide
(sul1) and tetracycline (tetA) resistance was observed to be at
11.43% and 5.71% of isolates, respectively (Table 1). Overall, we
observed low prevalence of resistance genes in concordance with
the phenotypic antibiotic resistances detected by disk diffusion
assays.
Virulence Associated Phenotypes
The isolates were analyzed for siderophore production, biofilm
formation, and serum resistance which are essential ExPEC
virulence properties. All pks-positive isolates formed orange
halos on Chrome Azurol S plates, confirming the production of
siderophores. Biofilm formation assay was performed twice in
triplicates for all the pks positive isolates in order to determine
their biofilm forming capabilities and was documented by specific
biofilm formation (SBF) values. Isolates showing SBF values
greater than 1 were designated as strong biofilm formers, 0.5–
1.0 as moderate biofilm formers and those showing less than 0.5
were considered as weak biofilm formers (Figure 1). Majority
(21/35) of the isolates tested were strong biofilm formers while
10/35 isolates moderately formed the biofilm and 4/35 isolates
were weak biofilm formers. Bacterial resistance to the bactericidal
activity of human serum was also assessed and the number
of CFU were found to be significantly higher for all the pks
positive isolates after 3 h of incubation in the human serum as
compared to the negative control, indicative of the fact that all
the isolates were resistant to human serum. Serum resistance was
performed twice in technical triplicate(s) (Figure 2) and p-values
were obtained using Mann–Whitney U test.
DISCUSSION
The pks island encodes enzymes that are able to synthesize
colibactin, a genotoxin that could induce host DNA damage
and its presence may contribute to increased virulence and
severe disease outcomes. Ever since the description of colibactin
by Nougayrède et al. (2006), many studies were undertaken
to develop a comprehensive understanding of this bacterial
genotoxin (Bossuet-Greif et al., 2018; Faïs et al., 2018). However,
epidemiological data on the prevalence of the same and factors
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FIGURE 1 | Biofilm formation in 35 pks positive E. coli isolates in M63 medium. Values are shown as mean of specific biofilm formation. Isolates demonstrating SBF
values > 1.0 were considered as strong, 0.5–1.0 as moderate and <0.5 as weak biofilm formers. Majority of isolates (21/35) demonstrated strong biofilm formation;
the remaining 10 and 4 isolates showed moderate and weak biofilm formation, respectively. NA097 was employed as a positive control in the biofilm formation assay.
FIGURE 2 | Serum resistance assay of pks-positive isolates in human serum. Mann–Whitney U test was carried out for calculating the significant differences.
Significant differences were indicated by asterisks and p ≤ 0.05 was considered to be significant. ∗p-value ≤ 0.05, ∗∗p-value ≤ 0.01. NA097 was taken as the
positive control, while DH5-α served as the negative control.
associated with pks-positive E. coli isolates, particularly from
the Southern World have not been documented. The present
study showed that 35 out of the 462 clinical ExPEC isolates
were positive for all the four genes, indicating the presence
of complete pks island(s) which might be able to synthesize
functional colibactin. Thus, the overall prevalence was found to
be 7.6% and this constitutes first epidemiological data on pks
island harboring E. coli from India. In contrast, reports from
other countries, such as those by Johnson et al. (2008) and
Shimpoh et al. (2017) demonstrated high pks prevalence among
clinical E. coli.
Our previous studies have suggested that majority of the
pks negative clinical E. coli from India were genetically diverse
and had a high prevalence of antibiotic resistance; these studies
also identified and characterized the clonally evolving pandemic
sequence type 131 E. coli isolates in India (Jadhav et al., 2011;
Ranjan et al., 2016; Hussain et al., 2017; Shaik et al., 2017).
However, the role of colibactin in the emergence of lineage
specific virulence in E. coli that were comparatively less resistant
to antibiotics has been shown herein for the first time from India.
Such lineages could become a matter of public health concern and
analysis of the underlying strains would be of great importance
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given the high burden of infectious diseases in this region.
Thus, the findings of this study have implications for better
understanding of the epidemiological context of pathogenic
E. coli in human diseases.
Escherichia coli harboring pks island was reported to be
strongly associated with bacteremia and human colorectal
tumors (Johnson et al., 2008; Buc et al., 2013). Recent reports
suggest that mice infected with colibactin positive E. coli had
significantly lower survival rates compared to those infected with
isogenic colibactin-negative mutant(s) (Marcq et al., 2014). It
has been further demonstrated that pks-positive E. coli infection
induces cellular senescence and concurrently produces growth
factors which promote tumor growth (Secher et al., 2013;
Cougnoux et al., 2014; Dalmasso et al., 2015). The pks-positive
E. coli isolates in the present study were detected in different
specimen types including urine, blood and pus. Therefore, it can
be surmised that the pks-positive E. coli might contribute in many
invasive and non-invasive infections at different anatomic sites.
Previous studies reported that the pks island was majorly
detected in E. coli phylogenetic group B2 strains, which are
mainly documented as extraintestinal pathogens (Taieb et al.,
2016; Sarshar et al., 2017). Our results were in line with
these observations as the pks-positive isolates in our study also
belonged predominantly to phylogroup B2 (97%), except for one
isolate which belonged to phylogroup D (3%) (Table 1). The
pathogenic strains of E. coli mainly belong to group B2 and, to
a lesser extent, group D and frequently harbor higher number of
virulence-factors than group A and group B1 strains (Picard et al.,
1999; Johnson et al., 2008).
Several studies have demonstrated a strong correlation
between the presence of virulence genes and the pathogenic
spectrum of E. coli strains (Bien et al., 2012). These include
multiple ExPEC-associated virulence genes such as adhesins,
invasins, secretory toxins, and iron scavenging systems (Johnson,
1991). Accordingly, the virulent nature of pks-positive E. coli
isolates was supported by our findings as 100% of them
were positive for fimH (D mannose specific adhesin of
minor fimbrial component), sfaD/E (s-fimbrial adhesin) and
usp (uropathogenic specific protein) while ≥ 30% of them
were positive for iucD (enzyme for siderophore aerobactin
synthesis), sat (secreted autotransporter vacuolating cytotoxin),
cvaC (colicin-V precursor) and ibeA (invasion protein). The
afimbrial adhesin gene, afa was found to be completely absent
(Table 1). These findings could be attributed to the pathogenic
potential of the pks-positive strains along with the presence of
many other virulence determinants. Furthermore, in the present
study, siderophore production was detected in all pks-positive
isolates; this observation was consistent with previous reports on
the positive correlation between the presence of pks island and
iron scavenging systems among the B2 E. coli strains (Martin
et al., 2017). The localization of pks island within the High-
Pathogenicity Island (HPI) and its physical association with
siderophore biosynthesis gene cluster has also been described
in other members of Enterobacteriaceae (Putze et al., 2009).
A majority of pks-positive E. coli isolates demonstrated high
biofilm forming capabilities in M63 medium (Figure 1) and
all the pks-positive isolates tested were found to be resistant to
serum bactericidal activity (Figure 2). We speculate that these
genotypic and phenotypic virulence traits expressed by B2 pks-
positive E. coli could act as fitness factors in order to colonize and
initiate/establish infection in intestinal and extra-intestinal sites.
Antibiotic susceptibility of the pks-positive isolates was
performed and the isolates were observed to be uniquely
associated with low antimicrobial resistance, this finding is
consistent with the previous reports which have suggested that
pks island harboring E. coli exhibit reduced antibiotic resistance
(Chen et al., 2017; Sarshar et al., 2017). This observation could
likely be due to opportunist E. coli infections arising from
intestinal microbiota. Additionally, detailed characterization of
such isolates from fecal and clinical samples is needed to
certainly understand the reason behind such an observation.
Multidrug resistance and ESBL production was observed in
only 11.42 and 37% isolates, respectively (Table 1). Previous
studies from our group have shown MDR rates of 95% for
clinical ST131 strains, and 91% for clinical and stool non-
ST131 strains (Hussain et al., 2014). We have also previously
reported MDR rates of 100% for metallo-(β-lactamase (MBL)
producing E. coli isolates (Ranjan et al., 2016) and 67% for
isolates from skin and soft tissue infections (Ranjan et al., 2017).
The pks positive isolates in contrast demonstrated lesser rates
of antimicrobial resistance compared to the pks negative isolates
characterized from the similar settings in our previous studies.
All nine blaCTXM−15 positive E. coli isolates were observed to
be ESBL producers (Table 1), although further screening for
other groups of CTX-M genes, and other ESBL classes are
warranted. In concordance with the antimicrobial susceptibility
results, molecular detection of antimicrobial resistance genes
showed a low prevalence of sul1 (sulphonamide resistance), tetA
(tetracycline resistance), aac(6′)-Ib (aminoglycoside resistance),
blaCTX−M−15 (extended spectrum-β-lactamases) and blaTEM−1
(broad spectrum-β-lactamases) genes (Table 1).
CONCLUSION
The prevalence of colibactin producing E. coli was found to
be moderate among clinical E. coli isolates in our collection.
These isolates harbored multiple virulence genes/traits and
demonstrated relatively low antimicrobial resistance. These
findings comprise essential baseline data required to understand
aspects of functional molecular infection epidemiology of
possibly genotoxic phenotypes of E. coli and their clinical
significance. We hope to extend these studies at genomic
and landscape scales to gain further insights into evolution,
adaptation and dissemination of such isolates at clinical,
community and ecosystem levels.
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